PULSE BIOSCIENCES INC
PULSE BIOSCIENCES INC logo
PLSE

PULSE BIOSCIENCES INC (PLSE)

$3.322.64%

Live
  • $

1D

1W

1M

1Y

3Y

5Y

Key Stats

$3.32
Day's Range
$3.45
$1.18
52-Week Range
$11.56
1 month return20.49%
3 month return63.16%
1 year return68.6%
5 year return82.4%

Analyst Recommendation

based on 7 analysts ratings

Hold
0%
Buy
57%
Hold
42%
Sell

Based on 7 Wall street analysts offering stock ratings for PULSE BIOSCIENCES INC(by analysts ranked 0 to 5 stars)

Analyst Forecast

What analysts predicted

Upside of 50.6%

Current

$3.32

Target

$5.0

Recommendation Trend

Based on 7 analyst

Current1M Ago3M Ago
Buy
0
3
0
Hold
4
0
4
Sell
3
0
3
Consensus
HOLD
BUY
HOLD

Company Financials

  • Annual
  • Quarterly

Highlights

Market Capitalization132.5M
Book Value$0.17
Dividend Share0.0
Dividend Yield0.0%
Earnings Per Share (EPS)-2.16
PEG Ratio0.0
Wall Street Target Price5.0

Valuation

Trailing PE0.0
Forward PE0.0
Price/Book (mrq)15.22
Enterprise Value100.4M
Enterprise Value/Revenue64.63
Enterprise Value/Ebitda-1.58

Technicals

Beta1.09
50 Day MA2.7
200 Day MA2.15

Institutional Holdings

Bank of America Corp

2.07%

Vanguard Group Inc

1.52%

BlackRock Inc

0.6%

Hovey Youngman Associates Inc

0.47%

Westside Investment Management, Inc.

0.39%

Geode Capital Management, LLC

0.36%

Company Information

Pulse Biosciences is a novel bioelectric medicine company committed to health innovation that has the potential to improve the quality of life for patients. The CellFX® System is the first commercial product to harness the distinctive advantages of the Company's proprietary Nano-Pulse Stimulation™ (NPS™) technology, such as the ability to non-thermally clear cells while sparing non-cellular tissue, to treat a variety of applications for which an optimal solution remains unfulfilled. Nano-Pulse Stimulation technology delivers nano-second pulses of electrical energy. The initial commercial use of the CellFX System is to address a range of dermatologic conditions that share high demand among patients and practitioners for improved dermatologic outcomes. Designed as a multi-application platform, the CellFX System offers customer value with a utilization-based revenue model.
OrganizationPULSE BIOSCIENCES INC
Employees142
CEOMr. Robert W. Duggan
IndustryHealth Technology

Discover more

Frequently Asked Questions

What is PULSE BIOSCIENCES INC share price today?

Can Indians buy PULSE BIOSCIENCES INC shares?

How can I buy PULSE BIOSCIENCES INC shares from India?

Can Fractional shares of PULSE BIOSCIENCES INC be purchased?

What are the documents required to start investing in PULSE BIOSCIENCES INC stocks?

What are today’s High and Low prices of PULSE BIOSCIENCES INC?

What are today’s traded volumes of PULSE BIOSCIENCES INC?

What is today’s market capitalisation of PULSE BIOSCIENCES INC?

What is the 52 Week High and Low Range of PULSE BIOSCIENCES INC?

How much percentage PULSE BIOSCIENCES INC is down from its 52 Week High?

How much percentage PULSE BIOSCIENCES INC is up from its 52 Week low?

What are the historical returns of PULSE BIOSCIENCES INC?

Who is the Chief Executive Officer (CEO) of PULSE BIOSCIENCES INC?

Trading and brokerage services provided by

Banking and Remittance services provided by

Technology services provided by : Finzoomers Services Private Limited

Disclaimer: These services are not for exchange traded products.The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Finzoomers Services Private Limited acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*